You are here : Home > MAB2 team > Patents of the team

Patents of the team

Published on 3 January 2022


Development & characterization of two monoclonal antibodies: Anti-EG-VEGF & anti-PROKR2


EB18180 ALFAIDY/AF EG-VEGF is a new biomarker for preeclampsia
EB18179 ALFAIDY/AF Use of PROKR2 antagonists to treat preeclampsia


PCT/EP2017/082321 Antagonist of Prokineticin receptor 2 for use as a medicament for treating an EG-VEGF-related cancer


EP16306666 Protected technology: Method of obtaining an animal model of a cancer, animal model and uses thereof